Acute myeloid leukemia with BCR-ABL1
MONDO:0035112Also known as: AML with BCR-ABL1, AML with t(9;22)(q34.1;q11.2), acute myeloid leukaemia with t(9;22)(q34.1;q11.2), acute myeloid leukemia with t(9;22)(q34.1;q11.2)
3098 clinical trials for this condition and its sub-types, 7 tagged with Acute myeloid leukemia with BCR-ABL1 itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
-
Could removing metals boost chemo in leukemia?
Disease control Recruiting nowThis phase 2 trial tests whether adding metal detoxification drugs (DMSA and Ca-EDTA) to standard therapy can improve outcomes for adults with intermediate- to high-risk acute myeloid leukemia (AML). Researchers believe lowering metal levels in blood and bone marrow may help cont…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Triple-Drug attack targets Hard-to-Treat leukemias
Disease control Recruiting nowThis early-phase study tests a combination of three drugs (decitabine, lisaftoclax, and olverembatinib) in 30 adults with advanced chronic myeloid leukemia or a related acute leukemia. The goal is to find safe doses and see if the combo can control the disease in people who have …
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Heart shield: new trial aims to prevent chemo side effects in blood cancer patients
Symptom relief Recruiting nowThis study tests whether a drug called dexrazoxane can protect the heart from damage caused by chemotherapy in people with certain blood cancers, such as acute myeloid leukemia and high-risk myelodysplastic syndrome. About 100 participants will receive dexrazoxane alongside stand…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC